Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion
NASDAQ:ESTA

Establishment Labs Q3 2026 Earnings Date & Estimates

Establishment Labs logo
$62.28 +1.21 (+1.98%)
Closing price 10/21/2026 04:00 PM Eastern
Extended Trading
$61.38 -0.90 (-1.44%)
As of 06:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Establishment Labs is scheduled to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens. The conference call is scheduled for 8:30 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:30 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Establishment Labs in Q3 2026

Establishment Labs is expected to post earnings of -$0.2568 per share on revenue of $66.81 million. In the same quarter a year earlier Establishment Labs reported -$0.38 per share on revenue of $53.78 million. Establishment Labs last reported on August 6, 2026, posting -$0.39 per share and missing the -$0.3368 consensus estimate. Establishment Labs has beaten the consensus EPS estimate in 4 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.2568
Expected Revenue
$66.81 million
Prior-Year EPS
-$0.38
Prior-Year Revenue
$53.78 million
Expected Revenue Growth
+24.2%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.39 (Missed by -$0.0532)
Last Quarter Revenue
$67.54 million
EPS Beat Rate
4 of last 8 quarters

Prepare for the Q3 2026 Call

Establishment Labs Q3 2026 Earnings FAQ

Establishment Labs (NASDAQ:ESTA) has confirmed it will report Q3 2026 earnings on Thursday, October 29, 2026, before market opens.

Establishment Labs' Q3 2026 earnings conference call is scheduled for Thursday, October 29, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Establishment Labs to post earnings of -$0.2568 per share for Q3 2026.

The consensus revenue estimate for Establishment Labs is $66.81 million for Q3 2026.

Establishment Labs Earnings Headlines

Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29
October 19 at 1:19 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/establishment-labs-announce-third-quarter-120000857.html
Establishment Labs (NASDAQ:ESTA) Stock Rating Reaffirmed as Buy by TD Cowen
October 17, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31127586
Federal Reserve’s Disturbing Plan To Control Your Money
A Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's visibility into consumer bank transactions. A pilot program is reportedly already underway, with wider rollout at major banks possibly beginning this summer. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what the document says and what steps account holders might consider.tc pixel
October 22 at 1:00 AM  |  Weiss Ratings (Ad)
Stifel Nicolaus Initiates Coverage on Establishment Labs With Buy Rating, $85 Price Target
October 16, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/stifel-nicolaus-initiates-coverage-establishment-114052286.html
Establishment Labs Holdings Inc. (ESTA) - What Are Researchers Thinking About This Stock?
October 16, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31124011
Establishment Labs a new Buy at Stifel on end-market prospects
October 15, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/establishment-labs-a-new-buy-at-stifel-on-end-market-prospects/ar-AA2ejm9R
See More Establishment Labs Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Establishment Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Establishment Labs and other key companies, straight to your email.

About Establishment Labs

Establishment Labs (NASDAQ:ESTA) is a medical technology company focused on women’s health and the breast aesthetics market. The company develops, manufactures and commercializes breast implants and related technologies designed for breast augmentation, reconstruction and revision procedures.

Its product portfolio includes the Motiva line of breast implants, which incorporates the company’s proprietary implant materials, surface technologies and design features. Establishment Labs also offers Motiva Flora tissue expanders for use in breast reconstruction and has developed Mia Femtech, a minimally invasive breast enhancement procedure intended to provide a less invasive alternative to traditional augmentation techniques.

Founded in 2004, Establishment Labs is headquartered in Costa Rica and serves physicians, hospitals and patients in international markets. Its products are distributed across multiple regions, including Europe, Latin America, Asia and other global markets, subject to applicable regulatory approvals. The company was co-founded by Juan José Chacón-Quesada, who serves as its chief executive officer.

View Establishment Labs Profile
Earnings Tools